Author： Allan G. Macielag M.
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.9, Iss.7, 1999-07, pp. : 955-962
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Progesterone Receptor Agonists and Antagonists as Anticancer Agents
Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 6, 2010-06 ,pp. :
Access to resources
Recommend
Progesterone antagonists and progesterone receptor modulators
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 10, 2003-10 ,pp. :
Muscarinic receptor agonists and antagonists
By Zlotos D.P. Bender W. Holzgrabe U.
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 8, 1999-08 ,pp. :
Cannabinoid receptor agonists and antagonists
By Barth F.
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 3, 1998-03 ,pp. :
Somatostatin receptor agonists and antagonists
Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 9, 2003-09 ,pp. :